• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, October 11, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Technology

Deep Learning Models Hit 98% Accuracy in Mammogram Breast Cancer Detection

by
October 11, 2026
in Technology
Reading Time: 5 mins read
0
Deep Learning Models Hit 98% Accuracy in Mammogram Breast Cancer Detection

Deep Learning Models Hit 98% Accuracy in Mammogram Breast Cancer Detection

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Breast cancer remains one of the most common cancers affecting women worldwide, and the single most powerful weapon against it is early detection. Mammography, the X-ray imaging of the breast, has been the gold standard for screening for decades, but reading mammograms is notoriously difficult. Radiologists must spot subtle differences in tissue density, tiny calcifications, and faint masses that can distinguish a malignant tumor from benign tissue, all while working through long queues of images. A new study published in Neural Computing and Applications now offers a detailed look at how pre-trained deep learning models perform on exactly this task, and how a simple but powerful technique called data augmentation can push their accuracy to levels that could meaningfully support clinical decision-making.

The research, conducted by Elham Tahsin Yasin, Ilkay Cinar, and Murat Koklu at Selcuk University in Turkey, set out to benchmark five well-known convolutional neural network architectures on mammographic image classification: DenseNet201, InceptionResNetV2, MobileNetV2, NASNetLarge, and Xception. Rather than building networks from scratch, the team used transfer learning, a strategy in which models pre-trained on millions of everyday images are repurposed for a specialized task. The underlying idea is that features learned from natural photographs, such as edges, textures, and shapes, provide a useful starting point that can be fine-tuned for the specific visual patterns of cancerous versus non-cancerous breast tissue.

The experimental design was deliberately comparative. Each of the five architectures was trained and evaluated under two distinct conditions: once using the original dataset of 745 mammographic images, and once using an expanded dataset of 9,685 images produced through data augmentation. Augmentation artificially enlarges a training set by applying transformations such as rotations, flips, and other image manipulations that preserve the diagnostic content of each image while creating new variations for the network to learn from. This matters enormously in medical imaging, where collecting thousands of annotated patient images is expensive, slow, and constrained by privacy regulations. The question the researchers posed was straightforward: how much does augmentation actually help when the task is distinguishing cancerous from non-cancerous mammograms?

The answer, it turns out, is quite a lot. Without augmentation, DenseNet201 led the field with an accuracy of 96.24 percent, followed closely by InceptionResNetV2 and Xception, both at 95.43 percent, NASNetLarge at 95.31 percent, and MobileNetV2 at 94.64 percent. Even in this baseline condition, the models demonstrated that transfer learning can extract clinically relevant information from a relatively small dataset of just 745 images. But the numbers climbed across the board once augmentation was applied to the larger dataset. DenseNet201 again took first place, improving to 98.06 percent accuracy, while MobileNetV2 reached 97.76 percent, Xception 97.67 percent, InceptionResNetV2 97.63 percent, and NASNetLarge 97.55 percent.

Several aspects of these results deserve attention. First, the gap between the best and worst models narrowed dramatically after augmentation, from roughly 1.6 percentage points to just half a point. This suggests that with sufficient training data, the choice of architecture becomes less critical than the quality and quantity of the training examples, a finding with practical implications for research groups with limited computational budgets. Second, MobileNetV2, the lightest and most computationally efficient model in the lineup, closed most of the gap with its heavier rivals, hinting that lightweight networks suitable for deployment in clinics with modest hardware could perform nearly as well as resource-hungry giants.

DenseNet201’s consistent dominance is also technically interesting. The DenseNet family of architectures is built around dense connectivity, in which each layer receives feature maps from all preceding layers. This design encourages feature reuse, strengthens gradient flow during training, and tends to perform well with limited data, which may explain why it excelled in both experimental conditions. Xception, by contrast, relies on depthwise separable convolutions that separate the processing of spatial patterns and cross-channel relationships, while NASNetLarge was discovered through automated neural architecture search rather than human design. The fact that all three approaches converge on similar performance after augmentation underscores a broader trend in the field: modern architectures have largely saturated the achievable accuracy on well-defined binary classification tasks, leaving data quality as the main lever for improvement.

The study is also notable for its explainability-aware framing. In medical applications, a model that simply outputs a percentage score is of limited use if clinicians cannot see why it reached its decision. Techniques such as gradient-weighted class activation mapping, which highlight the image regions most influential in a network’s prediction, have become central to building trust in artificial intelligence diagnostics. By benchmarking models with explainability in mind, the researchers align their work with a growing consensus that accuracy alone is not enough for clinical adoption; a model must also offer interpretable evidence that its attention falls on the actual lesion rather than on artifacts, imaging markers, or background tissue.

The dataset underpinning the study, known as Mammogram Mastery, was made publicly available through the Mendeley Data repository, which is significant for reproducibility. Medical imaging research has long been hampered by restricted access to patient data, and open datasets allow independent teams to verify results, compare methods on equal footing, and build cumulative knowledge. The researchers also employed stratified k-fold cross-validation, a rigorous evaluation strategy that preserves the class balance of cancerous and non-cancerous images across each validation split, reducing the risk that reported accuracies are inflated by lucky partitions of the data.

What do these numbers mean for patients? An accuracy of 98 percent on a binary classification task is impressive, but the path from benchmark to bedside involves many additional hurdles. Clinical systems must handle the full complexity of real screening practice, including different imaging devices, varying breast densities, image quality issues, and the far more granular classification schemes radiologists actually use, such as the BI-RADS categories. False positives generate unnecessary anxiety and biopsies, while false negatives can delay life-saving treatment, so the balance of sensitivity and specificity matters as much as raw accuracy. The authors’ results should therefore be read as strong evidence of feasibility rather than a claim of clinical readiness.

Nevertheless, the trajectory is clear and encouraging. The study demonstrates that data augmentation can lift the performance of pre-trained deep learning models by more than a full percentage point even at very high baseline accuracy, and that the resulting systems are accurate enough to serve as reliable second readers or triage tools that flag suspicious mammograms for priority review. As explainable artificial intelligence methods mature and open datasets grow, the combination of transfer learning, augmentation, and transparent decision-making may bring automated breast cancer detection from the research laboratory into routine screening practice, helping radiologists catch cancers earlier, when treatment is most effective.

Subject of Research: Explainability-aware benchmarking of pre-trained deep learning models for breast cancer classification in mammographic images

Article Title: Explainability-aware benchmarking of pre-trained deep learning models for breast cancer classification in mammographic images

Article References: Yasin, E. T., Cinar, I., & Koklu, M. (2026). Explainability-aware benchmarking of pre-trained deep learning models for breast cancer classification in mammographic images. Neural Computing and Applications, 38(19), Article 795. https://doi.org/10.1007/s00521-026-12513-1

Image Credits: AI Generated

DOI: 10.1007/s00521-026-12513-1

Keywords: breast cancer, mammography, deep learning, transfer learning, data augmentation, DenseNet201, convolutional neural networks, medical imaging, explainable AI, cancer screening, computer-aided diagnosis, benchmarking

News Source: Blake Davidson. (October 11, 2026). Deep Learning Models Hit 98% Accuracy in Mammogram Breast Cancer Detection. Scienmag.

Tags: benchmarkingBreast Cancercancer screeningcomputer-aided diagnosisconvolutional neural networksdata augmentationdeep learningDenseNet201Explainable AImammographyMedical ImagingTransfer Learning
Share12Tweet7Share2ShareShareShare1

Related Posts

AI Shows Promise but Remains Unproven for Assessing Fever in Returning Travellers

AI Shows Promise but Remains Unproven for Assessing Fever in Returning Travellers

October 11, 2026
Dual-path AI framework spots hidden anomalies in industrial time series data

Dual-path AI framework spots hidden anomalies in industrial time series data

October 11, 2026

Self-Powered Wearable Sensor Tracks Exercise Posture and Burns Calories With 95% Accuracy

October 11, 2026

Rheometer Tests Reveal How Ageing Quietly Transforms Roofing Bitumen

October 11, 2026

POPULAR NEWS

  • Alloys That Shrink Their Own Grains: New PIX Mechanism Refines Metals With Heat Alone

    Alloys That Shrink Their Own Grains: New PIX Mechanism Refines Metals With Heat Alone

    29 shares
    Share 12 Tweet 7
  • Endurance Exercise Reshapes the Liver in Males and Females Through Distinct Molecular Routes

    29 shares
    Share 12 Tweet 7
  • Single Transcription Factor PU.1 Rapidly Converts Fibroblasts into Macrophage-Lineage Cells

    29 shares
    Share 12 Tweet 7
  • New Scale Measures How Ready Nurse Educators Really Are for the AI Era

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Alloys That Shrink Their Own Grains: New PIX Mechanism Refines Metals With Heat Alone

Endurance Exercise Reshapes the Liver in Males and Females Through Distinct Molecular Routes

Single Transcription Factor PU.1 Rapidly Converts Fibroblasts into Macrophage-Lineage Cells

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.